Long-term erythropoietin therapy in children with thalassemia major.

Basit Öğe Kaydı
dc.contributor.authorAydinok, Y
dc.contributor.authorKavakli, K
dc.contributor.authorNisli, G
dc.date.accessioned2019-10-27T18:19:09Z
dc.date.available2019-10-27T18:19:09Z
dc.date.issued2001
dc.departmentEge Üniversitesien_US
dc.identifier.endpage20Ben_US
dc.identifier.issn0006-4971
dc.identifier.issue11en_US
dc.identifier.startpage19Ben_US
dc.identifier.urihttps://hdl.handle.net/11454/35613
dc.identifier.volume98en_US
dc.identifier.wosWOS:000172134200080en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAmer Soc Hematologyen_US
dc.relation.ispartofBlooden_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleLong-term erythropoietin therapy in children with thalassemia major.en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu